ENLV
Enlivex Therapeutics Ltd. NASDAQ Listed Jul 31, 2014$0.80
Mkt Cap $19.5M
52w Low $0.66
9.9% of range
52w High $2.10
50d MA $0.98
200d MA $1.05
P/E (TTM)
0.0x
EV/EBITDA
-2.1x
P/B
0.0x
Debt/Equity
0.0x
ROE
63.8%
P/FCF
-3.1x
RSI (14)
—
ATR (14)
—
Beta
1.68
50d MA
$0.98
200d MA
$1.05
Avg Volume
574.6K
Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.
14 Einstein Street · Ness Ziona 7403618 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | AMC | -0.03 | -0.23 | -666.7% | 0.90 | +2.2% | +3.3% | +3.5% | -1.1% | -8.2% | -4.6% | — |
| Mar 25, 2026 | AMC | -0.09 | 27.35 | +9999.0% | 1.20 | -2.5% | -9.2% | -3.7% | -14.3% | +3.3% | +3.5% | — |
| Nov 14, 2025 | AMC | -0.12 | -0.09 | +25.0% | 0.99 | -2.1% | -1.6% | +0.3% | -4.1% | -2.8% | -1.7% | — |
| Aug 29, 2025 | AMC | -0.16 | -0.08 | +50.0% | 1.05 | -1.0% | +1.0% | +0.0% | +0.9% | -0.9% | -1.9% | — |
| May 30, 2025 | AMC | -0.16 | -0.15 | +6.2% | 0.94 | +3.6% | +0.4% | +0.0% | -1.1% | -1.1% | +5.2% | — |
| Feb 26, 2025 | AMC | -0.16 | -0.24 | -47.8% | 1.00 | +5.0% | +3.0% | +16.5% | -15.0% | +5.9% | +4.6% | — |
| Nov 29, 2024 | AMC | -0.16 | -0.12 | +25.0% | 1.14 | -2.6% | -5.3% | +20.4% | +0.0% | -6.2% | +2.5% | — |
| Aug 30, 2024 | AMC | -0.22 | -0.16 | +27.3% | 1.30 | -3.8% | -3.1% | -2.4% | +0.0% | +3.3% | -5.5% | — |
| Jun 14, 2024 | AMC | -0.25 | -0.22 | +12.0% | 1.46 | -0.7% | -4.8% | -7.2% | +2.3% | +3.0% | +3.7% | — |
| Mar 29, 2024 | AMC | -0.28 | -0.48 | -71.4% | — | — | — | — | — | — | — | — |
| Nov 9, 2023 | AMC | -0.32 | -0.32 | +0.0% | 1.75 | +0.6% | +2.3% | -2.2% | -2.3% | +2.3% | -0.6% | — |
| Sep 1, 2023 | AMC | -0.43 | -0.37 | +14.0% | 2.35 | +1.3% | -0.9% | +0.4% | -0.9% | -5.2% | -12.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.87 | $0.90 | +3.3% | -4.6% | +12.0% | +1.8% | +1.3% | -12.8% |
| Jan 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.90 | $0.95 | +4.9% | +5.7% | -7.1% | +9.3% | -3.4% | +0.7% |
| Nov 24 | D. Boral Capital | Downgrade | Buy → Hold | — | $0.90 | $1.60 | +78.4% | +13.7% | -3.9% | -8.2% | +7.8% | -5.2% |
| Oct 29 | D. Boral Capital | Maintains | Buy → Buy | — | $1.08 | $1.09 | +0.9% | -0.9% | -1.9% | +0.0% | +0.0% | -1.9% |
| Sep 26 | D. Boral Capital | Maintains | Buy → Buy | — | $1.03 | $1.03 | +0.0% | +0.0% | -1.9% | +3.0% | -1.0% | +1.0% |
| Sep 12 | D. Boral Capital | Maintains | Buy → Buy | — | $1.07 | $1.05 | -1.9% | +0.0% | +0.0% | +0.9% | -2.8% | +0.0% |
| Sep 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.05 | $1.04 | -1.0% | +1.0% | +0.0% | +0.9% | -0.9% | -1.9% |
| Aug 22 | D. Boral Capital | Maintains | Buy → Buy | — | $1.03 | $1.01 | -1.9% | +1.9% | +2.9% | +0.0% | +0.9% | -4.6% |
| Aug 18 | D. Boral Capital | Maintains | Buy → Buy | — | $1.82 | $1.73 | -4.9% | -31.3% | -16.0% | +4.8% | -6.4% | +1.9% |
| Jul 29 | D. Boral Capital | Maintains | Buy → Buy | — | $1.26 | $1.30 | +3.2% | +12.7% | +8.5% | -3.2% | -2.7% | +2.1% |
| Jul 22 | D. Boral Capital | Maintains | Buy → Buy | — | $1.19 | $1.18 | -0.8% | -0.8% | -0.8% | -2.6% | -1.8% | +12.5% |
| Apr 21 | D. Boral Capital | Maintains | Buy → Buy | — | $0.86 | $0.86 | +0.1% | +2.3% | +1.1% | +3.4% | +4.3% | +2.6% |
| Apr 3 | D. Boral Capital | Maintains | Buy → Buy | — | $1.01 | $0.98 | -3.0% | -6.3% | -6.2% | +0.2% | +2.2% | +1.1% |
| Mar 24 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.05 | $1.12 | +6.7% | -2.9% | +6.9% | -3.7% | -3.8% | +1.0% |
| Mar 3 | D. Boral Capital | Maintains | Buy → Buy | — | $1.20 | $1.03 | -14.2% | -15.0% | +5.9% | +4.6% | +1.8% | +3.5% |
| Feb 7 | D. Boral Capital | Maintains | Buy → Buy | — | $1.03 | $1.01 | -1.9% | +6.8% | -0.9% | -2.8% | -0.9% | -1.0% |
| Dec 11 | D. Boral Capital | Maintains | Buy → Buy | — | $1.25 | $1.25 | +0.0% | +0.8% | -4.0% | -0.8% | -3.3% | +1.7% |
| Dec 3 | D. Boral Capital | Maintains | Buy → Buy | — | $1.08 | $1.22 | +13.0% | +20.4% | +0.0% | -6.2% | +2.5% | +2.4% |
| Nov 14 | D. Boral Capital | Maintains | Buy → Buy | — | $1.18 | $1.16 | -1.7% | -8.5% | -0.9% | -1.9% | -1.9% | -5.2% |
| Sep 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.58 | $1.59 | +0.6% | +3.8% | +2.4% | -4.2% | -3.7% | +1.9% |
| Sep 26 | EF Hutton | Maintains | Buy → Buy | — | $1.46 | $1.49 | +2.1% | +8.2% | +3.8% | +2.4% | -4.2% | -3.7% |
| Sep 24 | EF Hutton | Maintains | Buy → Buy | — | $1.48 | $1.50 | +1.4% | +0.0% | -1.4% | +8.2% | +3.8% | +2.4% |
| Sep 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.27 | $1.20 | -5.5% | -5.5% | +5.8% | +3.1% | +21.4% | -1.3% |
| Jun 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.36 | $1.38 | +1.5% | +4.4% | -2.1% | +6.5% | -1.4% | -4.8% |
| Apr 23 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.27 | $1.30 | +2.4% | +3.9% | +13.6% | -3.3% | -0.7% | +15.3% |
| Apr 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.83 | $1.89 | +3.3% | -13.7% | -17.7% | +11.5% | +2.1% | -5.4% |
| Sep 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.46 | $1.39 | -4.8% | +0.0% | +9.6% | +0.0% | -6.2% | +5.3% |
| Aug 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $2.56 | $2.56 | +0.0% | +5.1% | -0.4% | +10.8% | -4.0% | -4.2% |
| May 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.69 | $5.72 | +0.5% | -6.2% | -14.0% | -8.9% | -8.9% | +12.3% |
| Jun 16 | Roth Capital | Maintains | Buy → Buy | — | $269.60 | $284.00 | +5.3% | -6.5% | +2.5% | +7.4% | +1.6% | +3.5% |
| Jun 15 | Roth Capital | Maintains | Buy → Buy | — | $230.40 | $248.40 | +7.8% | +17.0% | -6.5% | +2.5% | +7.4% | +1.6% |
No insider trades available.
No recent filings available.
Data updated apr 25, 2026 7:10am
· Source: massive.com